CEL-SCI CORPORATION Operating Cash Flow
CEL-SCI CORPORATION (CVM) reported Operating Cash Flow of -$12.08 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.03M.
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.02M.
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.02M.
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.67M.
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was -$17.12M.
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was -$18.81M.
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was -$22.85M.
- CEL-SCI CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was -$18.24M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$4.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$8.05M derived: sum of 2 quarters · filed 2026-08-14 | -$12.08M 10-Q · filed 2026-08-14 | -$16.75M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$4.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$8.04M 10-Q · filed 2026-05-15 | -$12.72M derived: sum of 3 quarters · filed 2026-05-15 | -$16.65M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$4.02M 10-Q · filed 2026-02-17 | -$8.69M derived: sum of 2 quarters · filed 2026-02-17 | -$12.63M derived: sum of 3 quarters · filed 2026-08-14 | -$17.00M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-09-30 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$8.61M derived: sum of 2 quarters · filed 2026-08-14 | -$12.98M derived: sum of 3 quarters · filed 2026-08-14 | -$17.12M 10-K · filed 2025-12-29 | |
| 2025-06-30 | -$3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$8.31M derived: sum of 2 quarters · filed 2026-08-14 | -$12.45M 10-Q · filed 2026-08-14 | -$17.27M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$4.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$8.51M 10-Q · filed 2026-05-15 | -$13.33M derived: sum of 3 quarters · filed 2026-05-15 | -$17.91M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$4.14M 10-Q · filed 2026-02-17 | -$8.96M derived: sum of 2 quarters · filed 2026-02-17 | -$13.54M derived: sum of 3 quarters · filed 2026-02-17 | -$18.06M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | -$4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$9.40M derived: sum of 2 quarters · filed 2025-12-29 | -$13.92M derived: sum of 3 quarters · filed 2025-12-29 | -$18.81M 10-K · filed 2025-12-29 | |
| 2024-06-30 | -$4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | -$9.11M derived: sum of 2 quarters · filed 2025-08-14 | -$13.99M 10-Q · filed 2025-08-14 | -$13.99M 10-Q · filed 2024-08-14 | -$19.04M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$4.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | -$9.42M 10-Q · filed 2025-05-14 | -$14.46M derived: sum of 3 quarters · filed 2025-05-14 | -$20.13M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$4.89M 10-Q · filed 2025-02-14 | -$9.93M derived: sum of 2 quarters · filed 2025-02-14 | -$15.60M derived: sum of 3 quarters · filed 2025-02-14 | -$23.07M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | -$5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | -$10.71M derived: sum of 2 quarters · filed 2025-01-13 | -$18.18M derived: sum of 3 quarters · filed 2025-01-13 | -$22.85M 10-K · filed 2025-01-13 | |
| 2023-06-30 | -$5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | -$13.14M derived: sum of 2 quarters · filed 2024-08-14 | -$17.80M 10-Q · filed 2024-08-14 | -$22.72M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$7.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-15 | -$12.14M 10-Q · filed 2024-05-15 | -$17.05M derived: sum of 3 quarters · filed 2024-05-15 | -$22.84M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$4.67M 10-Q · filed 2024-02-14 | -$9.58M derived: sum of 2 quarters · filed 2024-02-14 | -$15.37M derived: sum of 3 quarters · filed 2024-02-14 | -$18.10M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | -$4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$10.70M derived: sum of 2 quarters · filed 2023-12-21 | -$13.44M derived: sum of 3 quarters · filed 2023-12-21 | -$18.24M 10-K · filed 2023-12-21 | |
| 2022-06-30 | -$5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-10 | -$8.52M derived: sum of 2 quarters · filed 2023-08-10 | -$13.33M 10-Q · filed 2023-08-10 | -$18.13M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$7.54M 10-Q · filed 2023-05-12 | -$12.34M derived: sum of 3 quarters · filed 2023-05-12 | -$17.54M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$4.81M 10-Q · filed 2023-02-14 | -$9.61M derived: sum of 2 quarters · filed 2023-02-14 | -$14.81M derived: sum of 3 quarters · filed 2023-02-14 | -$19.77M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | -$10.00M derived: sum of 2 quarters · filed 2022-12-27 | -$14.96M derived: sum of 3 quarters · filed 2022-12-27 | -$18.79M 10-K · filed 2022-12-27 | |
| 2021-06-30 | -$5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | -$10.16M derived: sum of 2 quarters · filed 2022-08-12 | -$13.98M 10-Q · filed 2022-08-12 | -$17.57M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$8.78M 10-Q · filed 2022-05-13 | -$12.37M derived: sum of 3 quarters · filed 2022-05-13 | -$16.07M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$3.83M 10-Q · filed 2022-02-11 | -$7.41M derived: sum of 2 quarters · filed 2022-02-11 | -$11.11M derived: sum of 3 quarters · filed 2022-02-11 | -$15.00M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-09-30 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | -$7.29M derived: sum of 2 quarters · filed 2021-12-21 | -$11.17M derived: sum of 3 quarters · filed 2021-12-21 | -$15.28M 10-K · filed 2021-12-21 | |
| 2020-06-30 | -$3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | -$7.59M derived: sum of 2 quarters · filed 2021-08-13 | -$11.69M 10-Q · filed 2021-08-13 | -$15.58M derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | -$3.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | -$7.99M 10-Q · filed 2021-05-17 | -$11.88M derived: sum of 3 quarters · filed 2021-05-17 | -$16.52M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$4.10M 10-Q · filed 2021-02-12 | -$7.99M derived: sum of 2 quarters · filed 2021-02-12 | -$12.63M derived: sum of 3 quarters · filed 2021-02-12 | -$16.26M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-09-30 | -$3.89M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | -$8.53M derived: sum of 2 quarters · filed 2020-12-31 | -$12.16M derived: sum of 3 quarters · filed 2020-12-31 | -$16.32M 10-K · filed 2020-12-29 | |
| 2019-06-30 | -$4.64M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2020-12-31 | -$8.28M derived: sum of 2 quarters · filed 2020-12-31 | -$12.43M 10-Q/A · filed 2020-12-31 | -$16.68M derived: sum of 4 quarters · filed 2020-12-31 | |
| 2019-03-31 | -$3.63M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2020-12-30 | -$7.79M 10-Q/A · filed 2020-12-30 | -$12.03M derived: sum of 3 quarters · filed 2020-12-30 | -$14.81M derived: sum of 4 quarters · filed 2020-12-30 | |
| 2018-12-31 | -$4.16M 10-Q/A · filed 2020-12-30 | -$8.40M derived: sum of 2 quarters · filed 2020-12-30 | -$11.18M derived: sum of 3 quarters · filed 2020-12-30 | -$14.93M derived: sum of 4 quarters · filed 2020-12-30 | |
| 2018-09-30 | -$4.24M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | -$7.02M derived: sum of 2 quarters · filed 2019-12-23 | -$10.78M derived: sum of 3 quarters · filed 2019-12-23 | -$13.39M 10-K/A · filed 2019-12-23 | |
| 2018-06-30 | -$2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -$6.53M derived: sum of 2 quarters · filed 2019-08-14 | -$9.14M 10-Q · filed 2019-08-14 | -$12.59M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | -$6.37M 10-Q · filed 2019-05-14 | -$9.81M derived: sum of 3 quarters · filed 2019-05-14 | -$12.93M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$2.61M 10-Q · filed 2019-02-14 | -$6.05M derived: sum of 2 quarters · filed 2019-02-14 | -$9.18M derived: sum of 3 quarters · filed 2019-02-14 | -$12.17M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-09-30 | -$3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | -$6.57M derived: sum of 2 quarters · filed 2018-12-19 | -$9.55M derived: sum of 3 quarters · filed 2018-12-19 | -$13.79M 10-K · filed 2018-12-19 | |
| 2017-06-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$6.11M derived: sum of 2 quarters · filed 2018-08-14 | -$10.35M 10-Q · filed 2018-08-14 | -$17.21M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | -$7.23M 10-Q · filed 2018-05-15 | -$14.09M derived: sum of 3 quarters · filed 2018-05-15 | -$19.50M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$4.24M 10-Q · filed 2018-02-12 | -$11.10M derived: sum of 2 quarters · filed 2018-02-12 | -$16.52M derived: sum of 3 quarters · filed 2018-02-12 | -$21.48M derived: sum of 4 quarters · filed 2018-02-12 | |
| 2016-09-30 | -$6.86M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | -$12.28M derived: sum of 2 quarters · filed 2017-12-29 | -$17.24M derived: sum of 3 quarters · filed 2017-12-29 | -$23.08M 10-K · filed 2017-12-29 | |
| 2016-06-30 | -$5.42M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | -$10.38M derived: sum of 2 quarters · filed 2017-12-11 | -$16.22M 10-Q/A · filed 2017-12-11 | -$21.56M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2016-03-31 | -$4.96M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | -$10.80M 10-Q/A · filed 2017-12-11 | -$16.15M derived: sum of 3 quarters · filed 2017-12-11 | -$22.39M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-12-31 | -$5.84M 10-Q/A · filed 2017-12-11 | -$11.18M derived: sum of 2 quarters · filed 2017-12-11 | -$17.43M derived: sum of 3 quarters · filed 2017-12-11 | -$24.23M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-09-30 | -$5.34M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | -$11.59M derived: sum of 2 quarters · filed 2017-12-11 | -$18.39M derived: sum of 3 quarters · filed 2017-12-11 | -$23.83M 10-K/A · filed 2017-12-11 | |
| 2015-06-30 | -$6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | -$13.05M derived: sum of 2 quarters · filed 2016-08-09 | -$18.49M 10-Q · filed 2016-08-09 | -$24.22M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-03-31 | -$6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | -$12.24M 10-Q · filed 2016-05-10 | -$17.97M derived: sum of 3 quarters · filed 2017-12-11 | -$24.00M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2014-12-31 | -$5.44M 10-Q · filed 2016-02-09 | -$11.17M derived: sum of 2 quarters · filed 2017-12-11 | -$17.19M derived: sum of 3 quarters · filed 2017-12-11 | -$22.45M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2014-09-30 | -$5.73M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | -$11.75M derived: sum of 2 quarters · filed 2017-12-11 | -$17.01M derived: sum of 3 quarters · filed 2017-12-11 | -$22.93M 10-K/A · filed 2017-12-11 | |
| 2014-06-30 | -$6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | -$11.28M derived: sum of 2 quarters · filed 2015-08-07 | -$17.20M 10-Q · filed 2015-08-07 | -$20.60M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2014-03-31 | -$5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | -$11.17M 10-Q · filed 2015-05-08 | -$14.58M derived: sum of 3 quarters · filed 2015-12-11 | -$18.05M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2013-12-31 | -$5.92M 10-Q · filed 2015-02-06 | -$9.32M derived: sum of 2 quarters · filed 2015-12-11 | -$12.79M derived: sum of 3 quarters · filed 2015-12-11 | -$16.47M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2013-09-30 | -$3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | -$6.88M derived: sum of 2 quarters · filed 2015-12-11 | -$10.55M derived: sum of 3 quarters · filed 2015-12-11 | -$13.55M 10-K · filed 2015-12-11 | |
| 2013-06-30 | -$3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | -$7.15M derived: sum of 2 quarters · filed 2014-08-08 | -$10.14M 10-Q · filed 2014-08-08 | -$13.41M derived: sum of 4 quarters · filed 2014-12-23 | |
| 2013-03-31 | -$3.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | -$6.67M 10-Q · filed 2014-05-12 | -$9.94M derived: sum of 3 quarters · filed 2014-12-23 | -$13.07M derived: sum of 4 quarters · filed 2014-12-23 | |
| 2012-12-31 | -$2.99M 10-Q · filed 2014-02-10 | -$6.26M derived: sum of 2 quarters · filed 2014-12-23 | -$9.39M derived: sum of 3 quarters · filed 2014-12-23 | -$12.57M derived: sum of 4 quarters · filed 2014-12-23 | |
| 2012-09-30 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | -$6.40M derived: sum of 2 quarters · filed 2014-12-23 | -$9.58M derived: sum of 3 quarters · filed 2014-12-23 | -$12.19M 10-K · filed 2014-12-23 | |
| 2012-06-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | -$6.31M derived: sum of 2 quarters · filed 2013-08-09 | -$8.92M 10-Q · filed 2013-08-09 | -$13.75M derived: sum of 4 quarters · filed 2013-12-27 | |
| 2012-03-31 | -$3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-10 | -$5.79M 10-Q · filed 2013-05-10 | -$10.62M derived: sum of 3 quarters · filed 2013-12-27 | -$17.80M derived: sum of 4 quarters · filed 2013-12-27 | |
| 2011-12-31 | -$2.61M 10-Q · filed 2013-02-08 | -$7.44M derived: sum of 2 quarters · filed 2013-12-27 | -$14.62M derived: sum of 3 quarters · filed 2013-12-27 | -$18.73M derived: sum of 4 quarters · filed 2013-12-27 | |
| 2011-09-30 | -$4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | -$12.01M derived: sum of 2 quarters · filed 2013-12-27 | -$16.12M derived: sum of 3 quarters · filed 2013-12-27 | -$22.56M 10-K · filed 2013-12-27 | |
| 2011-06-30 | -$7.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-09 | -$11.29M derived: sum of 2 quarters · filed 2012-08-09 | -$17.72M 10-Q · filed 2012-08-09 | -$21.46M derived: sum of 4 quarters · filed 2012-12-14 | |
| 2011-03-31 | -$4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-10 | -$10.55M 10-Q · filed 2012-05-10 | -$14.29M derived: sum of 3 quarters · filed 2012-12-14 | ||
| 2010-12-31 | -$6.43M 10-Q · filed 2012-02-09 | -$10.17M derived: sum of 2 quarters · filed 2012-12-14 | |||
| 2010-09-30 | -$3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | -$12.80M 10-K · filed 2012-12-14 | |||
| 2010-06-30 | -$9.06M 10-Q · filed 2011-08-09 | ||||
| 2009-09-30 | -$6.51M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |